This trial demonstrated a modest improvement in recurrence free survival in the group receiving the vaccine although this did not reach statistical significance (p = 0.078).
← all excerpts
Safety and efficacy of autologous cell vaccines in solid tumors: a systematic review and meta-analysis of randomized control trials.
1
0.0780
0.0780